封面
市場調查報告書
商品編碼
1825578

2025年全球椎體成形術和骨盆成形術市場報告

Vertebroplasty And Kyphoplasty Global Market Report 2025

出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年椎體成形術和骨盆整形手術市場規模將強勁成長,到2029年將達到12.7億美元,年複合成長率(CAGR)為5.4%。預測期內的成長可歸因於多種因素,例如老年護理服務的擴展、生物相容性骨水泥的開發、門診手術的普及、對價值導向型醫療保健的重視以及老年人口的成長。預測期內的主要趨勢包括脊椎介入治療的研發、門診手術中心的擴張、骨水泥的創新、手術技術的進步以及醫療成本控制和報銷挑戰。

未來五年5.4%的成長率預測比我們先前的預測略有下降,下降了0.2%。這一下降主要源自於美國與其他國家之間關稅的影響。預計關稅壁壘將阻礙美國,包括增加來自德國和台灣的聚甲基丙烯酸甲酯 (PMMA) 骨水泥和脊椎增強套件的成本、延遲骨折固定治療以及增加介入放射學支出。由於互惠關稅以及貿易緊張局勢和限制加劇對全球經濟和貿易的負面影響,其影響也將更加廣泛。

預計運動相關活動導致的脊椎損傷發病率不斷上升將推動椎體成形術和骨盆手術市場的成長。運動相關脊椎損傷是指因參與體育活動而導致的脊椎損傷。這些損傷包括脊椎骨壓迫性骨折、椎間滑脫和椎間盤突出等,通常需要微創治療,例如椎體成形術和骨盆手術。這些治療方法包括在受損脊椎骨注射骨水泥。例如,2023年11月,殘障人士服務機構紐西蘭脊髓信託基金(New Zealand Spinal Trust)報告稱,根據2022年NZSCIR數據,紐西蘭脊髓損傷發病率將從2021年的每百萬人41人上升至2022年的每百萬人45人,與2020年的每百萬人41人上升至2022年的每百萬人45人,與2020年的每百萬人相當44人。 2022年,74%的創傷性脊髓損傷(tSCI)患者為男性,而非創傷性脊髓損傷(NTSCI)患者為女性,佔33%。因此,運動相關脊髓損傷盛行率的上升預計將刺激椎體成形術和骨盆手術市場的擴張。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場:宏觀經濟情景,包括利率、通膨、地緣政治、貿易戰和關稅,以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球椎體成形術和骨盆成形術:PESTEL 分析(政治、社會、技術、環境、法律因素、促進因素和限制因素)
  • 最終用途產業分析
  • 全球椎體成形術與骨盆成形術市場:成長率分析
  • 全球椎體成形術與骨盆成形術市場表現:規模與成長,2019-2024
  • 全球椎體成形術與骨盆成形術市場預測:規模與成長,2024-2029 年,2034 年預測
  • 全球椎體成形術和骨盆成形術:總目標市場(TAM)

第6章 市場細分

  • 全球椎體成形術和骨盆成形術市場(按產品類型、性能和預測),2019-2024 年、2024-2029 年、2034 年
  • 經皮成形術裝置
  • 骨水泥治療裝置
  • 全球椎體成形術及骨盆成形術市場(依手術類型、績效及預測),2019-2024 年、2024-2029 年、2034 年
  • 骨水泥治療
  • 經皮成形術
  • 全球椎體成形術和骨盆成形術市場(按最終用戶、績效和預測),2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 門診手術中心
  • 全球椎體成形術及骨盆成形術市場:經經皮成形術器材細分(按類型)、績效及預測,2019-2024 年、2024-2029 年、2034 年
  • 球囊椎體後凸成形術裝置
  • 膨脹裝置
  • 脊椎修復裝置
  • 全球椎體成形術及骨盆成形術市場:骨水泥治療設備細分(類型)、績效及預測,2019-2024 年、2024-2029 年、2034 年
  • 骨水泥輸送系統
  • 套管和針頭
  • 全球椎體成形術及骨盆成形術市場:依脊椎切片檢查設備細分(按類型)、績效及預測,2019-2024 年、2024-2029 年、2034 年
  • 脊髓切片檢查裝置

第7章 區域和國家分析

  • 全球椎體成形術和骨盆成形術市場:按地區、績效和預測,2019-2024 年、2024-2029 年、2034 年
  • 全球椎體成形術及骨盆成形術市場:國家、績效及預測(2019-2024 年、2024-2029 年及 2034 年)

第8章 亞太市場

第9章:中國市場

第10章 印度市場

第11章 日本市場

第12章:澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章:德國市場

第18章:法國市場

第19章:義大利市場

第20章:西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章:加拿大市場

第26章 南美洲市場

第27章:巴西市場

第28章 中東市場

第29章:非洲市場

第30章:競爭格局與公司概況

  • 椎體成形術和骨盆成形術市場:競爭格局
  • 椎體成形術和骨盆成形術市場:公司簡介
    • Cardinal Health Overview, Products and Services, Strategy and Financial Analysis
    • Johnson and Johnson(DePuy Synthes)Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic Plc. Overview, Products and Services, Strategy and Financial Analysis
    • Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
    • GS Solutions Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章:其他領先和創新企業

  • Lepu Medical Technology(Beijing)Co.Ltd.
  • Merit Medical Systems Inc.
  • Globus Medical Inc.
  • Alphatec Spine Inc.
  • Rontis Corporation
  • Spectrum Plastics Group.
  • SOMATEX Medical Technologies GmbH
  • Zavation LLC
  • MJ Surgical
  • Benvenue Medical
  • Joimax GmbH
  • Laurane Medical LLC
  • Spine Wave Inc.
  • G21 Srl
  • BM Korea Co. LTD

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章:高潛力市場國家、細分市場與策略

  • 2029年椎體成形術和骨盆成形術市場:提供新機會的國家
  • 2029年椎體成形術和骨盆成形術市場:細分市場帶來新機會
  • 2029年椎體成形術和骨盆成形術市場:成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r29226u

Vertebroplasty and kyphoplasty are both minimally invasive surgical interventions employed to address non-healing vertebral compression fractures (VCFs) in the spine. These procedures entail the injection of polymethyl methacrylate (PMMA) into the vertebral body to reinforce its structure.

The primary products associated with vertebroplasty and kyphoplasty include kyphoplasty devices and vertebroplasty devices. Kyphoplasty devices are specialized medical tools designed for utilization in kyphoplasty procedures, applied in both vertebroplastic and kyphoplastic surgeries performed by hospitals and ambulatory surgical centers.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The vertebroplasty and kyphoplasty market research report is one of a series of new reports from The Business Research Company that provides vertebroplasty and kyphoplasty market statistics, including the vertebroplasty and kyphoplasty industry global market size, regional shares, competitors with vertebroplasty and kyphoplasty market share, detailed vertebroplasty and kyphoplasty market segments, market trends and opportunities, and any further data you may need to thrive in the vertebroplasty and kyphoplasty industry. This vertebroplasty and kyphoplasty market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The vertebroplasty and kyphoplasty market size has grown strongly in recent years. It will grow from $0.97 billion in 2024 to $1.03 billion in 2025 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to aging population and osteoporosis prevalence, advancements in minimally invasive techniques, rising awareness and diagnosis, increasing lifestyle-related factors, growing burden on healthcare systems.

The vertebroplasty and kyphoplasty market size is expected to see strong growth in the next few years. It will grow to $1.27 billion in 2029 at a compound annual growth rate (CAGR) of 5.4%. The growth in the forecast period can be attributed to expansion of geriatric care services, development of biocompatible bone cement, increased adoption of outpatient procedures, focus on value-based healthcare, growing geriatric population. Major trends in the forecast period include research and development in spinal interventions, expansion of ambulatory surgical centers, technological innovations in bone cement, technological advancements in procedures, healthcare cost containment and reimbursement challenges.

The forecast of 5.4% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. by increasing the cost of polymethylmethacrylate (PMMA) bone cement and spinal augmentation kits sourced from Germany and Taiwan, thereby delaying fracture stabilization and elevating interventional radiology expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing incidence of spinal injuries resulting from sports-related activities is expected to drive the growth of the vertebroplasty and kyphoplasty markets. Sports-related spinal injuries involve damage to the spine caused by participating in physical activities. The rise in such injuries includes conditions like vertebral compression fractures, spondylolisthesis, and herniated discs, which often require minimally invasive treatments such as vertebroplasty and kyphoplasty. These procedures involve injecting bone cement into damaged vertebrae. For example, in November 2023, the New Zealand Spinal Trust, a disability services organization, reported that the incidence rate in New Zealand reached 45 per million in 2022, up from 41 per million in 2021, which is comparable to the 44 per million recorded in 2020, according to 2022 NZSCIR data. In 2022, males accounted for 74% of those with traumatic spinal cord injuries (tSCI), while females made up 33% of those with non-traumatic spinal cord injuries (NTSCI). As a result, the growing prevalence of sports-related spinal injuries is anticipated to fuel the expansion of the vertebroplasty and kyphoplasty markets.

The growth of the vertebroplasty and kyphoplasty market is expected to be fueled by the increasing geriatric population. As individuals aged 65 and older often require specialized care due to age-related health needs, vertebroplasty and kyphoplasty procedures play a crucial role in providing minimally invasive solutions for alleviating pain and stabilizing vertebral compression fractures in the elderly. The World Health Organization projected that one-sixth of the global population would be 60 or older by 2030, reaching an estimated 2.1 billion elderly individuals by 2050. Therefore, the growing geriatric population is identified as a key driver for the expansion of the vertebroplasty and kyphoplasty market.

Leading companies in the vertebroplasty and kyphoplasty market are forming strategic partnerships to develop the unipedicular balloon catheter for treating vertebral compression fractures. Strategic partnerships involve companies leveraging their combined strengths and resources to achieve shared success. For example, in June 2024, Medtronic Plc, an Ireland-based medical technology firm, entered into a partnership with Merit Medical Systems Inc., a US-based medical device company. Through this collaboration, they aim to develop a unipedicular, steerable balloon catheter for treating vertebral compression fractures (VCF) in the United States. This partnership builds on the existing relationship between Medtronic and Merit, with Merit already supplying Medtronic's Kyphon Xpander Inflation Syringes for balloon kyphoplasty procedures. The Kyphon KyphoFlex is designed to enable controlled, precise, and targeted cavity creation during vertebral augmentation. This new unipedicular solution will complement Medtronic's current bipedicular balloon kyphoplasty offering, providing clinicians with greater flexibility and additional treatment options.

In October 2022, Halma PLC, a UK-based company focusing on safety, health, and environmental technologies, acquired IZI Medical Products LLC for $172.13 million. This strategic acquisition is aimed at strengthening Halma plc's portfolio in the healthcare sector, particularly in minimally invasive diagnosis and treatment, leveraging IZI Medical Products' expertise in vertebral compression fractures and related spinal issues, including vertebroplasty and kyphoplasty procedures.

Major companies operating in the vertebroplasty and kyphoplasty market report are Cardinal Health, Johnson and Johnson (DePuy Synthes), Medtronic Plc., Stryker Corporation, GS Solutions Inc., Lepu Medical Technology (Beijing)Co.Ltd., Merit Medical Systems Inc., Globus Medical Inc., Alphatec Spine Inc., Rontis Corporation, Spectrum Plastics Group., SOMATEX Medical Technologies GmbH, Zavation LLC, MJ Surgical, Benvenue Medical, Joimax GmbH, Laurane Medical LLC, Spine Wave Inc., G21 S.r.l., BM Korea Co. Ltd., Biopsybell Medical, Teknimed, Joline GmbH And Co. KG, SCW Medicath Ltd., Stockli Medical AG, Jiangsu ChangMei Medtech Co.Ltd., IZI Medical Products

North America was the largest region in the vertebroplasty and kyphoplasty market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vertebroplasty and kyphoplasty market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the vertebroplasty and kyphoplasty market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The vertebroplasty and kyphoplasty market consists of revenues earned by entities through services such as diagnostic evaluation services, consultations, post-operative care, and monitoring services to assist individuals with vertebral compression fractures and related conditions. The vertebroplasty and kyphoplasty market also includes sales of medical imaging equipment, pain management devices, and patient monitoring equipment that help in diagnosis, pain relief, and comprehensive patient care during and after procedures. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Vertebroplasty And Kyphoplasty Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on vertebroplasty and kyphoplasty market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for vertebroplasty and kyphoplasty ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The vertebroplasty and kyphoplasty market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Kyphoplasty Devices; Vertebroplasty Devices
  • 2) By Surgery Type: Vertebroplastic Surgery; Kyphoplastic Surgery
  • 3) By End User: Hospitals; Ambulatory Surgical Centers
  • Subsegments:
  • 1) By Kyphoplasty Devices: Balloon Kyphoplasty Devices; Inflation Devices; Vertebral Restoration Devices
  • 2) By Vertebroplasty Devices: Bone Cement Delivery Systems; Cannulas and Needles
  • 3) By Spinal Biopsy Devices: Spinal Biopsy Devices
  • Companies Mentioned: Cardinal Health; Johnson and Johnson (DePuy Synthes); Medtronic Plc.; Stryker Corporation; GS Solutions Inc.; Lepu Medical Technology (Beijing)Co.Ltd.; Merit Medical Systems Inc.; Globus Medical Inc.; Alphatec Spine Inc.; Rontis Corporation; Spectrum Plastics Group.; SOMATEX Medical Technologies GmbH; Zavation LLC; MJ Surgical; Benvenue Medical; Joimax GmbH; Laurane Medical LLC; Spine Wave Inc.; G21 S.r.l.; BM Korea Co. LTD; Biopsybell Medical; Teknimed; Joline GmbH And Co. KG; SCW Medicath Ltd.; Stockli Medical AG; Jiangsu ChangMei Medtech Co.Ltd.; IZI Medical Products
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Vertebroplasty And Kyphoplasty Market Characteristics

3. Vertebroplasty And Kyphoplasty Market Trends And Strategies

4. Vertebroplasty And Kyphoplasty Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Vertebroplasty And Kyphoplasty Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Vertebroplasty And Kyphoplasty PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Vertebroplasty And Kyphoplasty Market Growth Rate Analysis
  • 5.4. Global Vertebroplasty And Kyphoplasty Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Vertebroplasty And Kyphoplasty Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Vertebroplasty And Kyphoplasty Total Addressable Market (TAM)

6. Vertebroplasty And Kyphoplasty Market Segmentation

  • 6.1. Global Vertebroplasty And Kyphoplasty Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Kyphoplasty Devices
  • Vertebroplasty Devices
  • 6.2. Global Vertebroplasty And Kyphoplasty Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Vertebroplastic Surgery
  • Kyphoplastic Surgery
  • 6.3. Global Vertebroplasty And Kyphoplasty Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Ambulatory Surgical Centers
  • 6.4. Global Vertebroplasty And Kyphoplasty Market, Sub-Segmentation Of Kyphoplasty Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Balloon Kyphoplasty Devices
  • Inflation Devices
  • Vertebral Restoration Devices
  • 6.5. Global Vertebroplasty And Kyphoplasty Market, Sub-Segmentation Of Vertebroplasty Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bone Cement Delivery Systems
  • Cannulas and Needles
  • 6.6. Global Vertebroplasty And Kyphoplasty Market, Sub-Segmentation Of Spinal Biopsy Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Spinal Biopsy Devices

7. Vertebroplasty And Kyphoplasty Market Regional And Country Analysis

  • 7.1. Global Vertebroplasty And Kyphoplasty Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Vertebroplasty And Kyphoplasty Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Vertebroplasty And Kyphoplasty Market

  • 8.1. Asia-Pacific Vertebroplasty And Kyphoplasty Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Vertebroplasty And Kyphoplasty Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Vertebroplasty And Kyphoplasty Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Vertebroplasty And Kyphoplasty Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Vertebroplasty And Kyphoplasty Market

  • 9.1. China Vertebroplasty And Kyphoplasty Market Overview
  • 9.2. China Vertebroplasty And Kyphoplasty Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Vertebroplasty And Kyphoplasty Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Vertebroplasty And Kyphoplasty Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Vertebroplasty And Kyphoplasty Market

  • 10.1. India Vertebroplasty And Kyphoplasty Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Vertebroplasty And Kyphoplasty Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Vertebroplasty And Kyphoplasty Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Vertebroplasty And Kyphoplasty Market

  • 11.1. Japan Vertebroplasty And Kyphoplasty Market Overview
  • 11.2. Japan Vertebroplasty And Kyphoplasty Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Vertebroplasty And Kyphoplasty Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Vertebroplasty And Kyphoplasty Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Vertebroplasty And Kyphoplasty Market

  • 12.1. Australia Vertebroplasty And Kyphoplasty Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Vertebroplasty And Kyphoplasty Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Vertebroplasty And Kyphoplasty Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Vertebroplasty And Kyphoplasty Market

  • 13.1. Indonesia Vertebroplasty And Kyphoplasty Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Vertebroplasty And Kyphoplasty Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Vertebroplasty And Kyphoplasty Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Vertebroplasty And Kyphoplasty Market

  • 14.1. South Korea Vertebroplasty And Kyphoplasty Market Overview
  • 14.2. South Korea Vertebroplasty And Kyphoplasty Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Vertebroplasty And Kyphoplasty Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Vertebroplasty And Kyphoplasty Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Vertebroplasty And Kyphoplasty Market

  • 15.1. Western Europe Vertebroplasty And Kyphoplasty Market Overview
  • 15.2. Western Europe Vertebroplasty And Kyphoplasty Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Vertebroplasty And Kyphoplasty Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Vertebroplasty And Kyphoplasty Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Vertebroplasty And Kyphoplasty Market

  • 16.1. UK Vertebroplasty And Kyphoplasty Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Vertebroplasty And Kyphoplasty Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Vertebroplasty And Kyphoplasty Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Vertebroplasty And Kyphoplasty Market

  • 17.1. Germany Vertebroplasty And Kyphoplasty Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Vertebroplasty And Kyphoplasty Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Vertebroplasty And Kyphoplasty Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Vertebroplasty And Kyphoplasty Market

  • 18.1. France Vertebroplasty And Kyphoplasty Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Vertebroplasty And Kyphoplasty Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Vertebroplasty And Kyphoplasty Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Vertebroplasty And Kyphoplasty Market

  • 19.1. Italy Vertebroplasty And Kyphoplasty Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Vertebroplasty And Kyphoplasty Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Vertebroplasty And Kyphoplasty Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Vertebroplasty And Kyphoplasty Market

  • 20.1. Spain Vertebroplasty And Kyphoplasty Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Vertebroplasty And Kyphoplasty Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Vertebroplasty And Kyphoplasty Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Vertebroplasty And Kyphoplasty Market

  • 21.1. Eastern Europe Vertebroplasty And Kyphoplasty Market Overview
  • 21.2. Eastern Europe Vertebroplasty And Kyphoplasty Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Vertebroplasty And Kyphoplasty Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Vertebroplasty And Kyphoplasty Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Vertebroplasty And Kyphoplasty Market

  • 22.1. Russia Vertebroplasty And Kyphoplasty Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Vertebroplasty And Kyphoplasty Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Vertebroplasty And Kyphoplasty Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Vertebroplasty And Kyphoplasty Market

  • 23.1. North America Vertebroplasty And Kyphoplasty Market Overview
  • 23.2. North America Vertebroplasty And Kyphoplasty Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Vertebroplasty And Kyphoplasty Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Vertebroplasty And Kyphoplasty Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Vertebroplasty And Kyphoplasty Market

  • 24.1. USA Vertebroplasty And Kyphoplasty Market Overview
  • 24.2. USA Vertebroplasty And Kyphoplasty Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Vertebroplasty And Kyphoplasty Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Vertebroplasty And Kyphoplasty Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Vertebroplasty And Kyphoplasty Market

  • 25.1. Canada Vertebroplasty And Kyphoplasty Market Overview
  • 25.2. Canada Vertebroplasty And Kyphoplasty Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Vertebroplasty And Kyphoplasty Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Vertebroplasty And Kyphoplasty Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Vertebroplasty And Kyphoplasty Market

  • 26.1. South America Vertebroplasty And Kyphoplasty Market Overview
  • 26.2. South America Vertebroplasty And Kyphoplasty Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Vertebroplasty And Kyphoplasty Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Vertebroplasty And Kyphoplasty Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Vertebroplasty And Kyphoplasty Market

  • 27.1. Brazil Vertebroplasty And Kyphoplasty Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Vertebroplasty And Kyphoplasty Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Vertebroplasty And Kyphoplasty Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Vertebroplasty And Kyphoplasty Market

  • 28.1. Middle East Vertebroplasty And Kyphoplasty Market Overview
  • 28.2. Middle East Vertebroplasty And Kyphoplasty Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Vertebroplasty And Kyphoplasty Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Vertebroplasty And Kyphoplasty Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Vertebroplasty And Kyphoplasty Market

  • 29.1. Africa Vertebroplasty And Kyphoplasty Market Overview
  • 29.2. Africa Vertebroplasty And Kyphoplasty Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Vertebroplasty And Kyphoplasty Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Vertebroplasty And Kyphoplasty Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Vertebroplasty And Kyphoplasty Market Competitive Landscape And Company Profiles

  • 30.1. Vertebroplasty And Kyphoplasty Market Competitive Landscape
  • 30.2. Vertebroplasty And Kyphoplasty Market Company Profiles
    • 30.2.1. Cardinal Health Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Johnson and Johnson (DePuy Synthes) Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Medtronic Plc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. GS Solutions Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Vertebroplasty And Kyphoplasty Market Other Major And Innovative Companies

  • 31.1. Lepu Medical Technology (Beijing)Co.Ltd.
  • 31.2. Merit Medical Systems Inc.
  • 31.3. Globus Medical Inc.
  • 31.4. Alphatec Spine Inc.
  • 31.5. Rontis Corporation
  • 31.6. Spectrum Plastics Group.
  • 31.7. SOMATEX Medical Technologies GmbH
  • 31.8. Zavation LLC
  • 31.9. MJ Surgical
  • 31.10. Benvenue Medical
  • 31.11. Joimax GmbH
  • 31.12. Laurane Medical LLC
  • 31.13. Spine Wave Inc.
  • 31.14. G21 S.r.l.
  • 31.15. BM Korea Co. LTD

32. Global Vertebroplasty And Kyphoplasty Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Vertebroplasty And Kyphoplasty Market

34. Recent Developments In The Vertebroplasty And Kyphoplasty Market

35. Vertebroplasty And Kyphoplasty Market High Potential Countries, Segments and Strategies

  • 35.1 Vertebroplasty And Kyphoplasty Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Vertebroplasty And Kyphoplasty Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Vertebroplasty And Kyphoplasty Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer